FABRIS, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 19.325
EU - Europa 2.380
AS - Asia 1.860
AF - Africa 12
SA - Sud America 11
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.597
Nazione #
US - Stati Uniti d'America 19.315
CN - Cina 880
SG - Singapore 634
IT - Italia 623
FI - Finlandia 479
SE - Svezia 297
DE - Germania 290
VN - Vietnam 255
FR - Francia 236
UA - Ucraina 214
GB - Regno Unito 142
IN - India 44
IE - Irlanda 33
NL - Olanda 24
JP - Giappone 14
CA - Canada 9
IR - Iran 8
MA - Marocco 8
CH - Svizzera 7
HK - Hong Kong 7
TR - Turchia 6
AR - Argentina 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
AU - Australia 4
RU - Federazione Russa 4
BG - Bulgaria 3
BR - Brasile 3
EU - Europa 3
IL - Israele 3
TW - Taiwan 3
CO - Colombia 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
NZ - Nuova Zelanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BE - Belgio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SM - San Marino 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 23.597
Città #
Fairfield 3.477
Woodbridge 2.216
Houston 1.716
Ashburn 1.326
Ann Arbor 1.308
Seattle 1.287
Wilmington 1.233
Chandler 1.221
Cambridge 1.197
Jacksonville 1.031
Princeton 522
Singapore 486
San Diego 350
Dong Ket 255
Medford 222
Roxbury 220
Beijing 190
Helsinki 190
Nanjing 190
Padova 161
Des Moines 107
Santa Clara 92
Boardman 87
Hebei 65
Nanchang 65
Guangzhou 63
Norwalk 54
Shenyang 53
New York 49
Jiaxing 48
London 41
Jinan 34
Dublin 32
Changsha 31
Redwood City 31
Milan 29
Tianjin 27
Kilburn 19
Rome 18
Ogden 15
Borås 12
Catania 12
Indiana 10
Kharkiv 10
Dearborn 9
Hefei 9
Florence 8
Palermo 8
Kunming 7
Lanzhou 7
Orange 7
Rockville 7
Tappahannock 7
Bologna 6
Detroit 6
Hangzhou 6
Legnaro 6
Ningbo 6
Osaka 6
Paris 6
Castiglione 5
Haikou 5
Naples 5
Rabat 5
San Francisco 5
Washington 5
Yellow Springs 5
Zhengzhou 5
Acton 4
Costa Mesa 4
Dronten 4
Falls Church 4
Frankfurt am Main 4
Guardiagrele 4
Hong Kong 4
Hounslow 4
Messina 4
Monselice 4
Montesilvano Marina 4
Monza 4
Mykolayiv 4
Nutley 4
Perugia 4
Selargius 4
Selvazzano Dentro 4
Verona 4
Zurich 4
Ailoche 3
Amsterdam 3
Ardabil 3
Atlanta 3
Auburn Hills 3
Azzano San Paolo 3
Bitonto 3
Brno 3
Budapest 3
Cedar Knolls 3
Cervignano del Friuli 3
Colombelles 3
Dallas 3
Totale 20.068
Nome #
Low vitamin K1 intake in haemodialysis patients 193
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 192
Mappatura Genetica dell' Ipercolesterolemia Familiare: dati preliminari dell'esperienza padovana 188
Vitamin K plasma levels determination in human health 171
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 170
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 166
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 165
Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia. 154
Weight loss reduces anti-ADAMTS13 autoantibodies and improves inflammatory and coagulative parameters in obese patients 149
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 137
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod 136
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 136
Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement. 133
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. 130
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 129
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients 126
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 125
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 125
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 124
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 124
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia 121
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 121
Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia 119
Presence of anti-ADAMTS13 antibodies in obesity. 118
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. 117
Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. 117
Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multi-center Italian study 115
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 114
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 113
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 113
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 110
Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis 110
Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. 110
Sindromi mieloproliferative croniche: La trombocitemia essenziale 109
Selection of both normal and bleeding patients is indicated before desmopressin administration 108
Multiple, relapsing thrombosis in a young man with primary thrombocytosis 108
A tentative classification of factor XIII deficiency in two groups. 108
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. 108
Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies. 107
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 107
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations. 107
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 107
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011 107
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis 107
Splenomegaly as the first manifestation of thyroid cancer metastases 105
Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia. 105
Heparin induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies 105
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the Jak2 (V617F) mutation 105
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. 105
Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission 105
The significance of plasma and /or platelet activated products after apheresis procedures 104
Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura. 103
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients. 103
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 102
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. 101
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 101
A 29-year-old woman with persistent thrombocytopenia 101
The significance of thrombocytosis in old age 100
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 99
New heterozygous variant in GP1BB gene is responsible for an inherited form of macrothrombocytopenia 99
A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding. 98
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 98
Spectrum of the Mutations in Bernard-Soulier Syndrome 98
Normal and low molecular weight heparins: interaction with human platelets 97
Clinical and laboratory factors that affect the post-transfusion platelet increment 96
Familial thrombocythemia and/or thrombocytosis: apparently a rare disorder 95
Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. 95
Labeling of platelet surface glycoproteins with biotin derivatives 95
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients 95
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. 94
Additional evidence against the presence of inhibitors in vit. K deficiency and in coumarin-treated patients. 94
Heavy chain myosin 9-related disease (MYH9 -RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 94
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 94
JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia. 93
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 93
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation: Implications for Risk and Therapy. 92
Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. 92
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 92
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura 92
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 91
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation 91
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature 90
A 40-years-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis 90
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A. 90
HOW MANY CHILDREN WITH THROMBOCYTOSIS OF UNDEFINED ORIGIN HAVE A MYELOPROLIFERATIVE NEOPLASM? 89
Broken heart in elderly patients: two clinical observations. 89
Clinical significance of beta-thromboglobulin in patients with high platelet count 89
Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies. 89
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosis 89
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 89
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 89
Genetic Diagnosis of Familial Hypercholesterolaemia: preliminary data from the University of Padua outpatient lipid clinic. 88
Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study 88
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 88
Hydroxyurea in old patients with essential thrombocythemia 87
Effect of busulfan on JAK2V617F allele burden. 87
Idiopathic erythrocytosis: a study of a large cohort with a long follow-up 87
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 87
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 86
Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. 85
Totale 10.952
Categoria #
all - tutte 81.322
article - articoli 79.648
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.378 0 0 0 360 448 340 401 544 984 582 433 286
2020/20214.208 299 336 299 251 139 208 67 449 505 549 421 685
2021/20224.315 104 478 389 504 205 266 159 478 249 84 398 1.001
2022/20232.676 683 189 88 275 398 308 17 215 315 33 124 31
2023/20241.210 64 152 118 115 81 99 63 50 43 22 191 212
2024/2025952 29 469 347 107 0 0 0 0 0 0 0 0
Totale 23.849